These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 25676117)

  • 1. RNA and protein expression of HLA-A(∗)23:19Q.
    Gerritsen KE; Voorter CE; Joannes MO; Senden-Gijsbers BL; Agis F; Wieten L; Tilanus MG
    Hum Immunol; 2015 Apr; 76(4):286-91. PubMed ID: 25676117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of HLA-A*0111N: a synonymous substitution, introducing an alternative splice site in exon 3, silenced the expression of an HLA-A allele.
    Reinders J; Rozemuller EH; Otten HG; Houben AJ; Dormoy A; Mulder A; van den Tweel JG; Petersen EJ; Tilanus MG
    Hum Immunol; 2005 Aug; 66(8):912-20. PubMed ID: 16216676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved and validated RNA HLA class I SBT approach for obtaining full length coding sequences.
    Gerritsen KE; Olieslagers TI; Groeneweg M; Voorter CE; Tilanus MG
    Tissue Antigens; 2014 Nov; 84(5):450-8. PubMed ID: 25251784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination of HLA null and low expression alleles by cytokine-induced secretion of recombinant soluble HLA.
    Hinrichs J; Figueiredo C; Hirv K; Mytilineos J; Blasczyk R; Horn PA; Eiz-Vesper B
    Mol Immunol; 2009 Apr; 46(7):1451-7. PubMed ID: 19195705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closing the gap: discrimination of the expression profile of HLA questionable alleles by a cytokine-induced secretion approach using HLA-A*32:11Q.
    Föll D; Hinrichs J; Tischer S; Battermann A; Schambach A; Figueiredo C; Immenschuh S; Blasczyk R; Eiz-Vesper B
    Tissue Antigens; 2012 May; 79(5):340-50. PubMed ID: 22489943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A "silent" nucleotide substitution in exon 4 is responsible for the "alternative expression" of HLA-A*01:01:38L through aberrant splicing.
    Dunn PP; Hammond L; Coates E; Street J; Griner L; Darke C
    Hum Immunol; 2011 Sep; 72(9):717-22. PubMed ID: 21741421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA processing and protein expression of HLA-B*07:44N.
    Balas A; García-Sánchez F; Vicario JL
    HLA; 2017 Apr; 89(4):230-234. PubMed ID: 28205408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a new HLA-A*29 allele, HLA-A*290102 by sequence-based typing in a Chinese individual.
    Zhu FM; Zhang W; He J; Yan LX
    Tissue Antigens; 2009 Aug; 74(2):168-9. PubMed ID: 19500317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel alleles HLA-A*02:433 and HLA-A*02:434 identified in Saudi bone marrow donors using sequence-based typing.
    Fakhoury HA; Jawdat D; Alaskar AS; Al Jumah M; Cereb N; Hajeer AH
    Int J Immunogenet; 2014 Aug; 41(4):338-9. PubMed ID: 24919814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A deletion in exon 3 results in a new HLA-A*01 null allele (A*0115N) in a Martinican woman.
    Béra O; Dubois V; Assaqa A; Belon P; Favre-Victoire I; Gebuhrer L
    Tissue Antigens; 2006 Jan; 67(1):61-3. PubMed ID: 16451203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-based typing of HLA: an improved group-specific full-length gene sequencing approach.
    Voorter CE; Palusci F; Tilanus MG
    Methods Mol Biol; 2014; 1109():101-14. PubMed ID: 24473781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new non-expressed allele HLA-A*03:168N, identified by serological and sequence-based typing in a voluntary Norwegian hematopoietic stem cell donor.
    Abad ML; Balas A; Andersen I; Rodríguez-Calvo MI; Eiras A; Vicario JL
    Tissue Antigens; 2014 Mar; 83(3):195-6. PubMed ID: 24397317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5' and 3' untranslated regions contribute to the differential expression of specific HLA-A alleles.
    René C; Lozano C; Villalba M; Eliaou JF
    Eur J Immunol; 2015 Dec; 45(12):3454-63. PubMed ID: 26399450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach to HLA typing designed for solid organ transplantation: epityping and its application to the HLA-A locus.
    Lougee E; Morjaria S; Shaw O; Collins R; Vaughan R
    Int J Immunogenet; 2013 Dec; 40(6):445-52. PubMed ID: 23586471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrelated donor HLA re-typing effort to verify prevalence of newer alleles: HLA-A*24:23, A*30:10, DRB1*08:11, DRB1*15:03, and DRB1*15:06.
    Kempenich J; Dehn J; Flickinger G; Setterholm M
    Tissue Antigens; 2014 Nov; 84(5):489-91. PubMed ID: 25244652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel HLA-A*24:215 allele, identified by sequencing-based typing of a stem cell transplant patient and the sibling donor.
    Plaisier L; Geerts N; van Ginkel W; van der Weerd R; Spierings E
    Tissue Antigens; 2013 Aug; 82(2):138-9. PubMed ID: 23849071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenetics of HLA null alleles: implications for blood stem cell transplantation.
    Elsner HA; Blasczyk R
    Tissue Antigens; 2004 Dec; 64(6):687-95. PubMed ID: 15546342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Description of novel class I alleles encountered during routine registry typing in 2007.
    Lazaro AM; Xiao Y; Masaberg C; Nichol L; Ivaskova E; Banwart R; Field E; Ng J; Hurley CK; Posch PE
    Tissue Antigens; 2009 Sep; 74(3):238-40. PubMed ID: 19523144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence-based typing of the HLA-A10/A19 group and confirmation of a pseudogene coamplified with A*3401.
    Swelsen WT; Voorter CE; van den Berg-Loonen EM
    Hum Immunol; 2005 May; 66(5):535-42. PubMed ID: 15935891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exon 1-4 sequence analysis of a novel HLA-A allele, HLA-A*2458.
    Danzer M; Polin H; Faé I; Fischer GF; Gabriel C
    Tissue Antigens; 2006 Aug; 68(2):177-8. PubMed ID: 16866891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.